Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS vaccine development: perspectives, challenges & hopes.

Jean-Louis Excler1

  • 1International AIDS Vaccine Initiative India, 193, 1st Floor, Jor Bagh, New Delhi 110 003, India. jlexcler@iavi.org

The Indian Journal of Medical Research
|April 9, 2005
PubMed
Summary

Developing an AIDS vaccine is a critical 21st-century challenge. Accelerating research through parallel approaches and clinical trials is key to creating effective HIV vaccines that induce both antibody and cell-mediated immunity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges ahead.

Vaccine·2026
Same author

Need, demand, and feasibility for a new iNTS vaccine: stakeholder insights from eight African countries.

NPJ vaccines·2026
Same author

Estimating the economic burden of invasive non-typhoidal <i>Salmonella</i> infections in low- and middle-income countries.

BMJ global health·2025
Same author

Longevity of immune-response provided by at least one dose of vi-DT vaccine 5 years after vaccination among healthy Filipino adults and children.

Vaccine·2025
Same author

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations.

Vaccine·2025

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • The global effort to develop an Acquired Immunodeficiency Syndrome (AIDS) vaccine is a significant scientific and humanitarian challenge.
  • Preventive vaccines are considered the most viable long-term strategy to control the Human Immunodeficiency Virus (HIV) epidemic.
  • AIDS vaccines are essential to complement existing prevention methods.

Purpose of the Study:

  • To outline the multifaceted global endeavor to create an effective AIDS vaccine.
  • To highlight the importance of parallel scientific approaches and clinical trials in accelerating vaccine development.
  • To emphasize the ideal characteristics of an AIDS vaccine, including induction of neutralizing antibodies and cell-mediated immunity.

Main Methods:

  • Exploring diverse scientific approaches, including vector-based vaccines (e.g., modified vaccinia Ankara, adeno-associated virus, adenovirus, alpha viruses).

Related Experiment Videos

  • Focusing on strategies to induce both cell-mediated immune responses and neutralizing antibodies against HIV-1.
  • Conducting clinical trials, with some advanced candidates in Phase II and efficacy testing.

    • Main Results:

    • Current vaccine candidates are designed to elicit cell-mediated immunity or neutralizing antibodies.
    • All tested vaccines in human trials have demonstrated a strong safety profile.
    • Advancements in vaccine development are progressing, with some candidates entering later-stage trials.

    Conclusions:

    • An effective AIDS vaccine should ideally induce both neutralizing antibodies and cell-mediated responses to prevent infection, disease progression, and transmission.
    • The development requires sustained political will, scientific collaboration, and community engagement.
    • India's commitment underscores the global dedication to achieving an AIDS-free future through vaccination.